Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Vectors | 19 | 2023 | 1718 | 1.650 |
Why?
|
| Adenoviridae | 14 | 2020 | 1458 | 1.360 |
Why?
|
| Genetic Therapy | 13 | 2020 | 1631 | 1.150 |
Why?
|
| Receptors, LDL | 7 | 2016 | 112 | 0.750 |
Why?
|
| Atherosclerosis | 8 | 2015 | 970 | 0.670 |
Why?
|
| Retina | 2 | 2020 | 547 | 0.630 |
Why?
|
| Helper Viruses | 4 | 2008 | 56 | 0.580 |
Why?
|
| Gene Transfer Techniques | 8 | 2020 | 725 | 0.520 |
Why?
|
| Apolipoproteins E | 4 | 2015 | 220 | 0.410 |
Why?
|
| Hyperlipidemias | 2 | 2004 | 244 | 0.380 |
Why?
|
| Interleukin-7 | 1 | 2011 | 96 | 0.380 |
Why?
|
| Cholesterol | 6 | 2016 | 677 | 0.360 |
Why?
|
| Frailty | 2 | 2024 | 130 | 0.360 |
Why?
|
| Macrophages | 5 | 2015 | 1376 | 0.330 |
Why?
|
| Apolipoprotein A-I | 5 | 2015 | 86 | 0.320 |
Why?
|
| Monocytes | 1 | 2011 | 785 | 0.290 |
Why?
|
| Islets of Langerhans | 3 | 2014 | 233 | 0.280 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 904 | 0.280 |
Why?
|
| Dependovirus | 2 | 2023 | 141 | 0.270 |
Why?
|
| Frail Elderly | 2 | 2024 | 122 | 0.260 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2014 | 623 | 0.230 |
Why?
|
| Genetic Techniques | 1 | 2005 | 131 | 0.230 |
Why?
|
| Capsid | 1 | 2023 | 104 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2015 | 229 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2016 | 1424 | 0.210 |
Why?
|
| Geriatric Assessment | 1 | 2024 | 288 | 0.200 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2014 | 366 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2016 | 856 | 0.190 |
Why?
|
| Cell Line | 4 | 2020 | 5122 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 12 | 2016 | 7210 | 0.190 |
Why?
|
| Cause of Death | 1 | 2024 | 791 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 3 | 2014 | 1475 | 0.180 |
Why?
|
| Sarcopenia | 1 | 2021 | 113 | 0.180 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2020 | 30 | 0.170 |
Why?
|
| Arteriosclerosis | 3 | 2006 | 181 | 0.170 |
Why?
|
| Neurons | 2 | 2014 | 2415 | 0.160 |
Why?
|
| Retinitis Pigmentosa | 1 | 2020 | 85 | 0.160 |
Why?
|
| Heart Failure | 2 | 2024 | 2674 | 0.160 |
Why?
|
| Down-Regulation | 3 | 2016 | 2110 | 0.160 |
Why?
|
| Eye Proteins | 1 | 2020 | 277 | 0.150 |
Why?
|
| Mice | 23 | 2016 | 35455 | 0.150 |
Why?
|
| Cells, Cultured | 6 | 2016 | 5677 | 0.150 |
Why?
|
| Mice, Knockout | 10 | 2016 | 5810 | 0.150 |
Why?
|
| Animals | 26 | 2016 | 61175 | 0.150 |
Why?
|
| Nuclear Proteins | 3 | 2014 | 3362 | 0.140 |
Why?
|
| Perilipin-2 | 1 | 2015 | 31 | 0.130 |
Why?
|
| Integrases | 3 | 2009 | 268 | 0.130 |
Why?
|
| Foam Cells | 1 | 2015 | 31 | 0.130 |
Why?
|
| Antigen-Presenting Cells | 1 | 2016 | 289 | 0.130 |
Why?
|
| Brain | 1 | 2009 | 4219 | 0.130 |
Why?
|
| HEK293 Cells | 1 | 2020 | 1509 | 0.130 |
Why?
|
| Cell Cycle Proteins | 2 | 2014 | 2093 | 0.130 |
Why?
|
| Liver | 5 | 2012 | 2993 | 0.120 |
Why?
|
| Chromosome Pairing | 1 | 2014 | 9 | 0.120 |
Why?
|
| Cell Movement | 2 | 2013 | 2510 | 0.120 |
Why?
|
| Hypercholesterolemia | 1 | 2016 | 267 | 0.120 |
Why?
|
| Protein Isoforms | 1 | 2016 | 848 | 0.120 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2014 | 64 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 444 | 0.110 |
Why?
|
| Meiosis | 1 | 2014 | 174 | 0.110 |
Why?
|
| Lentivirus | 1 | 2014 | 172 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2015 | 257 | 0.110 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2015 | 167 | 0.110 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 415 | 0.110 |
Why?
|
| RNA, Messenger | 3 | 2014 | 6221 | 0.110 |
Why?
|
| Appetite | 1 | 2013 | 70 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2015 | 339 | 0.100 |
Why?
|
| Ganglia, Spinal | 2 | 2014 | 245 | 0.100 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2011 | 14 | 0.100 |
Why?
|
| Apolipoprotein E3 | 1 | 2011 | 17 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 671 | 0.100 |
Why?
|
| CREB-Binding Protein | 1 | 2011 | 93 | 0.100 |
Why?
|
| Tauopathies | 1 | 2011 | 61 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2013 | 264 | 0.090 |
Why?
|
| Neuralgia | 1 | 2014 | 255 | 0.090 |
Why?
|
| Chemokine CCL2 | 1 | 2011 | 205 | 0.090 |
Why?
|
| beta-Hexosaminidase beta Chain | 1 | 2009 | 3 | 0.090 |
Why?
|
| Sandhoff Disease | 1 | 2009 | 4 | 0.090 |
Why?
|
| Dietary Fats | 2 | 2008 | 352 | 0.090 |
Why?
|
| Lipoproteins, IDL | 1 | 2009 | 5 | 0.090 |
Why?
|
| Lipoproteins, LDL | 2 | 2009 | 166 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 4061 | 0.080 |
Why?
|
| Venoms | 1 | 2008 | 24 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 1581 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 582 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 2216 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2011 | 2474 | 0.080 |
Why?
|
| Transgenes | 2 | 2009 | 573 | 0.070 |
Why?
|
| B7-H1 Antigen | 1 | 2014 | 1061 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2009 | 246 | 0.070 |
Why?
|
| Transfection | 1 | 2012 | 2987 | 0.070 |
Why?
|
| DNA Primers | 2 | 2011 | 1413 | 0.070 |
Why?
|
| Aorta | 5 | 2015 | 707 | 0.070 |
Why?
|
| Autoimmunity | 1 | 2009 | 271 | 0.070 |
Why?
|
| Humans | 18 | 2024 | 270969 | 0.070 |
Why?
|
| Hepatocytes | 1 | 2009 | 351 | 0.070 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2006 | 19 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 3098 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 2009 | 220 | 0.070 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 573 | 0.070 |
Why?
|
| Lipoproteins, VLDL | 1 | 2006 | 89 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 1296 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 3148 | 0.070 |
Why?
|
| Hypertension | 2 | 2006 | 1576 | 0.070 |
Why?
|
| Disease Models, Animal | 7 | 2016 | 7456 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2009 | 599 | 0.070 |
Why?
|
| Astrocytes | 1 | 2009 | 382 | 0.060 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2005 | 71 | 0.060 |
Why?
|
| Blotting, Southern | 1 | 2005 | 404 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2009 | 566 | 0.060 |
Why?
|
| Smad3 Protein | 1 | 2006 | 136 | 0.060 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2005 | 81 | 0.060 |
Why?
|
| Cerebellum | 1 | 2009 | 467 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2009 | 632 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2006 | 199 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 1710 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2011 | 1585 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 335 | 0.060 |
Why?
|
| Ultracentrifugation | 1 | 2023 | 49 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 5228 | 0.060 |
Why?
|
| Japan | 1 | 2024 | 227 | 0.060 |
Why?
|
| Quality Control | 1 | 2005 | 459 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2023 | 256 | 0.050 |
Why?
|
| Base Sequence | 2 | 2011 | 4903 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 1507 | 0.050 |
Why?
|
| Peptides | 1 | 2008 | 1504 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2005 | 443 | 0.050 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2003 | 83 | 0.050 |
Why?
|
| Dyslipidemias | 1 | 2005 | 244 | 0.050 |
Why?
|
| Female | 10 | 2024 | 147624 | 0.050 |
Why?
|
| Stem Cells | 1 | 2009 | 1248 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2009 | 1693 | 0.050 |
Why?
|
| Betacellulin | 2 | 2012 | 7 | 0.050 |
Why?
|
| Virus Replication | 1 | 2005 | 715 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2024 | 7105 | 0.050 |
Why?
|
| Prognosis | 3 | 2024 | 22348 | 0.050 |
Why?
|
| Cholesterol, Dietary | 2 | 2015 | 56 | 0.050 |
Why?
|
| Lipoproteins, HDL | 2 | 2015 | 149 | 0.040 |
Why?
|
| Obesity | 2 | 2013 | 2983 | 0.040 |
Why?
|
| Spleen | 2 | 2014 | 698 | 0.040 |
Why?
|
| Gene Expression | 4 | 2015 | 3574 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 3218 | 0.040 |
Why?
|
| Male | 11 | 2024 | 127769 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2021 | 418 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 1950 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2016 | 1699 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2014 | 12145 | 0.040 |
Why?
|
| Liver X Receptors | 1 | 2016 | 30 | 0.040 |
Why?
|
| Mutation | 2 | 2014 | 15640 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2011 | 4239 | 0.040 |
Why?
|
| CD11c Antigen | 1 | 2016 | 57 | 0.040 |
Why?
|
| Time Factors | 3 | 2024 | 13261 | 0.030 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2016 | 41 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 220 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 261 | 0.030 |
Why?
|
| Sex Factors | 1 | 2021 | 2198 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 3954 | 0.030 |
Why?
|
| Cholesterol Esters | 1 | 2015 | 33 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 2717 | 0.030 |
Why?
|
| Streptozocin | 1 | 2015 | 73 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2016 | 907 | 0.030 |
Why?
|
| Centromere | 1 | 2014 | 95 | 0.030 |
Why?
|
| Age Factors | 1 | 2024 | 5498 | 0.030 |
Why?
|
| Chromatids | 1 | 2014 | 77 | 0.030 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2014 | 31 | 0.030 |
Why?
|
| Neuropeptide Y | 1 | 2014 | 46 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 602 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 3399 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 1502 | 0.030 |
Why?
|
| Drinking Behavior | 1 | 2013 | 14 | 0.030 |
Why?
|
| Injections, Intraventricular | 1 | 2013 | 115 | 0.030 |
Why?
|
| Hyperphagia | 1 | 2013 | 47 | 0.030 |
Why?
|
| Infertility, Female | 1 | 2014 | 216 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 909 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 386 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 753 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2013 | 175 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 676 | 0.020 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2013 | 135 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2013 | 698 | 0.020 |
Why?
|
| Aged | 4 | 2024 | 73018 | 0.020 |
Why?
|
| Glucose | 2 | 2008 | 1272 | 0.020 |
Why?
|
| Microglia | 1 | 2013 | 178 | 0.020 |
Why?
|
| Fasting | 1 | 2013 | 355 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 838 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 2014 | 338 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2010 | 153 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 3069 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 770 | 0.020 |
Why?
|
| Pedigree | 1 | 2014 | 1876 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2015 | 742 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2009 | 19 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 1062 | 0.020 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2009 | 16 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2014 | 1058 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2014 | 7333 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 1078 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2024 | 13336 | 0.020 |
Why?
|
| Receptors, Glucagon | 1 | 2008 | 36 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 932 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2014 | 1175 | 0.020 |
Why?
|
| Calgranulin B | 1 | 2008 | 23 | 0.020 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2008 | 67 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 1324 | 0.020 |
Why?
|
| Cell Transdifferentiation | 1 | 2009 | 126 | 0.020 |
Why?
|
| Transcriptome | 1 | 2016 | 1963 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2013 | 1472 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 1231 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2013 | 1615 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 18036 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2013 | 828 | 0.020 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2006 | 41 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2006 | 55 | 0.020 |
Why?
|
| DNA Repair | 1 | 2014 | 1879 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2006 | 66 | 0.020 |
Why?
|
| Eating | 1 | 2008 | 438 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2006 | 98 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 3594 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 2406 | 0.020 |
Why?
|
| Hippocampus | 1 | 2011 | 942 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2009 | 583 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2005 | 123 | 0.020 |
Why?
|
| Mifepristone | 1 | 2005 | 153 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 494 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 30845 | 0.010 |
Why?
|
| Homeostasis | 1 | 2009 | 943 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2009 | 1186 | 0.010 |
Why?
|
| Organ Size | 1 | 2005 | 733 | 0.010 |
Why?
|
| Disease Progression | 2 | 2006 | 6881 | 0.010 |
Why?
|
| Insulin | 1 | 2009 | 1475 | 0.010 |
Why?
|
| Time | 1 | 2003 | 183 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2004 | 360 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 883 | 0.010 |
Why?
|
| DNA | 1 | 2009 | 2733 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 7756 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 3242 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 3660 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 1521 | 0.010 |
Why?
|
| Heart | 1 | 2005 | 1261 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2009 | 3037 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2009 | 4182 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 5431 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 7711 | 0.010 |
Why?
|
| Adult | 2 | 2009 | 80872 | 0.010 |
Why?
|
| Middle Aged | 2 | 2009 | 89661 | 0.010 |
Why?
|
| Adolescent | 1 | 2009 | 32464 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2003 | 34335 | 0.000 |
Why?
|